Table: Torii Pharmaceutical - 6-MTH parent results
Jul 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 31.38 28.31
(+10.8 pct) (+10.2 pct)
Operating 3.15 3.14
(+0.4 pct) (+107.9 pct)
Recurring 3.47 2.99
(+16.2 pct) (+93.5 pct)
Net 2.59 2.22
(+16.5 pct) (+104.4 pct)
EPS 92.08 yen 79.04 yen
Ann Div 120.00 yen NIL
-Q2 div NIL 60.00 yen
-Q4 div 60.00 yen NIL
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)